ResMed Inc. stock falls 2.20 percent, ending two-day winning streak

4 articles · Updated · MarketWatch · Apr 28

Shares closed at $217.14 on Tuesday, underperforming the S&P 500 and Dow Jones, with trading volume reaching 1.5 million, above the 50-day average.
The decline left ResMed Inc. 26.10% below its 52-week high of $293.81, last reached on August 22nd.
The drop occurred during a broader market downturn, as major indices also posted losses in a rough trading session.

ResMed's earnings are soaring, so why is its stock in a 'downward spiral'?

Insiders are selling ResMed shares. Do they know something investors don't?

With its main rival sidelined, how will ResMed defend its market dominance long-term?

Can ResMed's digital health ecosystem survive the rise of weight-loss drugs?

Is ResMed's new AI algorithm a true game-changer for sleep apnea patients?